Abstract
Genetic instability is a striking feature of human cancers, with an impact on the genesis, progression and prognosis. The clinical importance of genomic instability and aneuploidy is underscored by its association with poor patient outcome in multiple cancer types, including breast and colon cancer. Interestingly, there is growing evidence that prognostic gene expression signatures simply reflect the degree of genomic instability. Additionally, also the proteome is affected by aneuploidy and has therefore become a powerful tool to screen for new targets for therapy, diagnosis and prognostication. In this context, the chapter presents the impact of genomic instability on disease prognostication occurring in human cancers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akeson M, Jakobsen AM, Zetterqvist BM, Holmberg E, Brannstrom M, Horvath G (2009) A population-based 5-year cohort study including all cases of epithelial ovarian cancer in western Sweden: 10-year survival and prognostic factors. Int J Gynecol Cancer: Off J Int Gynecol Cancer Soc 19:116–123
Ashktorab H, Belgrave K, Hosseinkhah F, Brim H, Nouraie M, Takkikto M, Hewitt S, Lee EL, Dashwood RH, Smoot D (2009) Global histone H4 acetylation and HDAC2 expression in colon adenoma and carcinoma. Dig Dis Sci 54:2109–2117
Auer GU, Caspersson TO, Wallgren AS (1980) DNA content and survival in mammary carcinoma. Analytical and quantitative cytology 2:161–165
Bakhoum SF, Danilova OV, Kaur P, Levy NB, Compton DA (2011) Chromosomal instability substantiates poor prognosis in patients with diffuse large B-cell lymphoma. Clin Cancer Res: Off J Am Assoc Cancer Res 17:7704–7711
Bartek J, Bartkova J, Vojtesek B, Staskova Z, Rejthar A, Kovarik J, Lane DP (1990) Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. Int J Cancer (Journal international du cancer) 46:839–844
Bondi J, Pretorius M, Bukholm I, Danielsen H (2009) Large-scale genomic instability in colon adenocarcinomas and correlation with patient outcome. APMIS acta pathologica, microbiologica, et immunologica Scandinavica 117:730–736
Bosari S, Lee AK, Wiley BD, Heatley GJ, Hamilton WM, Silverman ML (1992) DNA quantitation by image analysis of paraffin-embedded colorectal adenocarcinomas and its prognostic value. Mod Pathol 5:324–328
Britton LC, Wilson TO, Gaffey TA, Lieber MM, Wieand HS, Podratz KC (1989) Flow cytometric DNA analysis of stage I endometrial carcinoma. Gynecol Oncol 34:317–322
Britton LC, Wilson TO, Gaffey TA, Cha SS, Wieand HS, Podratz KC (1990) DNA ploidy in endometrial carcinoma: major objective prognostic factor. Mayo Clin Proc 65:643–650
Cascinu S, Del Ferro E, Grianti C, Ligi M, Catalano G (1996) S-phase fraction and tumor aneuploidy in colorectal carcinoma of young patients. Cancer 78:1857–1860
Chen HS, Sheen-Chen SM, Lu CC (2002) DNA index and S-phase fraction in curative resection of colorectal adenocarcinoma: analysis of prognosis and current trends. World J Surg 26:626–630
Coradini D, Daidone MG (2004) Biomolecular prognostic factors in breast cancer. Curr Opin Obstet Gynecol 16:49–55
Evans MP, Podratz KC (1996) Endometrial neoplasia: prognostic significance of ploidy status. Clin Obstet Gynecol 39:696–706
Fallenius AG, Franzen SA, Auer GU (1988) Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. A retrospective study of 227 consecutive cases. Cancer 62:521–530
Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767
Ferguson NL, Bell J, Heidel R, Lee S, Vanmeter S, Duncan L, Munsey B, Panella T, Orucevic A (2013) Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women. Breast J 19:22–30
Flyger HL, Larsen JK, Nielsen HJ, Christensen IJ (1999) DNA ploidy in colorectal cancer, heterogeneity within and between tumors and relation to survival. Cytometry 38:293–300
Garrity MM, Burgart LJ, Mahoney MR, Windschitl HE, Salim M, Wiesenfeld M, Krook JE, Michalak JC, Goldberg RM, O’Connell MJ, Furth AF, Sargent DJ, Murphy LM, Hill E, Riehle DL, Meyers CH, Witzig TE (2004) Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes’ B2 or C colon cancer: a north central cancer treatment group study. J Clin Oncol 22:1572–1582
Gemoll T, Roblick UJ, Szymczak S, Braunschweig T, Becker S, Igl BW, Bruch HP, Ziegler A, Hellman U, Difilippantonio MJ, Ried T, Jornvall H, Auer G, Habermann JK (2011) HDAC2 and TXNL1 distinguish aneuploid from diploid colorectal cancers. Cell Mol Life Sci CMLS 68:3261–3274
Gemoll T, Habermann JK, Lahmann J, Szymczak S, Lundgren C, Bundgen NK, Jungbluth T, Nordstrom B, Becker S, Lomnytska MI, Bruch HP, Ziegler A, Hellman U, Auer G, Roblick UJ, Jornvall H (2012) Protein profiling of genomic instability in endometrial cancer. Cell Mol Life Sci CMLS 69:325–333
Gerling M, Meyer KF, Fuchs K, Igl BW, Fritzsche B, Ziegler A, Bader F, Kujath P, Schimmelpenning H, Bruch HP, Roblick UJ, Habermann JK (2010) High frequency of aneuploidy defines ulcerative colitis-associated carcinomas: a comparative prognostic study to sporadic colorectal carcinomas. Ann Surg
Guastadisegni C, Colafranceschi M, Ottini L, Dogliotti E (2010) Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data. Eur J Cancer 46:2788–2798
Habermann JK, Doering J, Hautaniemi S, Roblick UJ, Bundgen NK, Nicorici D, Kronenwett U, Rathnagiriswaran S, Mettu RK, Ma Y, Kruger S, Bruch HP, Auer G, Guo NL, Ried T (2009) The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome. Int J Cancer (Journal international du cancer) 124:1552–1564
Habermann JK, Brucker CA, Freitag-Wolf S, Heselmeyer-Haddad K, Kruger S, Barenboim L, Downing T, Bruch HP, Auer G, Roblick UJ, Ried T (2011a) Genomic instability and oncogene amplifications in colorectal adenomas predict recurrence and synchronous carcinoma. Mod Pathol 24:542–555
Habermann JK, Bundgen NK, Gemoll T, Hautaniemi S, Lundgren C, Wangsa D, Doering J, Bruch HP, Nordstroem B, Roblick UJ, Jornvall H, Auer G, Ried T (2011b) Genomic instability influences the transcriptome and proteome in endometrial cancer subtypes. Molecular cancer 10:132
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Ikeda M, Watanabe Y, Nanjoh T, Noda K (1993) Evaluation of DNA ploidy in endometrial cancer. Gynecol Oncol 50:25–29
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
Jimenez A, Pelto-Huikko M, Gustafsson JA, Miranda-Vizuete A (2006) Characterization of human thioredoxin-like-1: potential involvement in the cellular response against glucose deprivation. FEBS Lett 580:960–967
Kearney TJ, Price EA, Lee S, Silberman AW (1993) Tumor aneuploidy in young patients with colorectal cancer. Cancer 72:42–45
Kildal W, Kaern J, Kraggerud SM, Abeler VM, Sudbo J, Trope CG, Lothe RA, Danielsen HE (2004) Evaluation of genomic changes in a large series of malignant ovarian germ cell tumors—relation to clinicopathologic variables. Cancer Genet Cytogenet 155:25–32
Kristensen GB, Kildal W, Abeler VM, Kaern J, Vergote I, Trope CG, Danielsen HE (2003) Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer. Ann Oncol 14:1494–1500
Kronenwett U, Ploner A, Zetterberg A, Bergh J, Hall P, Auer G, Pawitan Y (2006) Genomic instability and prognosis in breast carcinomas. Cancer Epidemiol Biomark Prev 15:1630–1635 (A publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)
Laubert T, Bente V, Freitag-Wolf S, Voulgaris H, Oberlander M, Schillo K, Kleemann M, Burk C, Bruch HP, Roblick UJ, Habermann JK (2013) Aneuploidy and elevated CEA indicate an increased risk for metachronous metastasis in colorectal cancer. Int J Colorectal Dis 28:767–775
Lundgren C, Auer G, Frankendal B, Moberger B, Nilsson B, Nordstrom B (2002) Nuclear DNA content, proliferative activity, and p53 expression related to clinical and histopathologic features in endometrial carcinoma. Int J Gynecol Cancer: Off J Int Gynecol Cancer Soc 12:110–118
Mai J, Waisman DM, Sloane BF (2000) Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. Biochim Biophys Acta 1477:215–230
Manandhar G, Miranda-Vizuete A, Pedrajas JR, Krause WJ, Zimmerman S, Sutovsky M, Sutovsky P (2009) Peroxiredoxin 2 and peroxidase enzymatic activity of mammalian spermatozoa. Biol Reprod 80:1168–1177
McGranahan N, Burrell RA, Endesfelder D, Novelli MR, Swanton C (2012) Cancer chromosomal instability: therapeutic and diagnostic challenges. EMBO Rep 13:528–538
Mettu RK, Wan YW, Habermann JK, Ried T, Guo NL (2010) A 12-gene genomic instability signature predicts clinical outcomes in multiple cancer types. Int J Biol Mark 25:219–228
Nakagawa Y, Numoto K, Yoshida A, Kunisada T, Ohata H, Takeda K, Wai D, Poremba C, Ozaki T (2006) Chromosomal and genetic imbalances in synovial sarcoma detected by conventional and microarray comparative genomic hybridization. J Cancer Res Clin Oncol 132:444–450
Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351:2817–2826
Pinto AE, Andre S, Nogueira M, Mendonca E, Soares J (1997) Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer. J Clin Pathol 50:591–595
Ried T, Heselmeyer-Haddad K, Blegen H, Schrock E, Auer G (1999) Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosom Cancer 25:195–204
Sato H, Uzawa N, Takahashi K, Myo K, Ohyama Y, Amagasa T (2010) Prognostic utility of chromosomal instability detected by fluorescence in situ hybridization in fine-needle aspirates from oral squamous cell carcinomas. BMC Cancer 10:182
Schillaci A, Tirindelli DD, Ferri M, Teodori L, Mauro F, Nicolanti V, Stipa S (1990) Flow cytometric analysis in colorectal carcinoma: prognostic significance of cellular DNA content. Int J Colorectal Dis 5:223–227
Sidoni A, Cavaliere A, D’Amico GA, Brachelente G, Bucciarelli E (2001) Biopathological significance of single cell DNA aneuploidy measured by static cytometry in breast cancer. Breast 10:325–329
Siitonen SM, Kallioniemi OP, Helin HJ, Isola JJ (1993) Prognostic value of cells with more than 5c DNA content in node-negative breast cancer as determined by image cytometry from tissue sections. Hum Pathol 24:1348–1353
Silvestrini R (2000) Relevance of DNA-ploidy as a prognostic instrument for solid tumors. Ann Oncol 11:259–261
Sinicrope FA, Rego RL, Halling KC, Foster N, Sargent DJ, La Plant B, French AJ, Laurie JA, Goldberg RM, Thibodeau SN, Witzig TE (2006) Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology 131:729–737
Song J, Su H, Zhou YY, Guo LL (2013) Prognostic value of survivin expression in breast cancer patients: a meta-analysis. Tumour Biol: J Int Soc Oncodev Biol Med 34:2053–2062
Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lonning PE, Brown PO, Borresen-Dale AL, Botstein D (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418–8423
Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL, Liu ET (2003) Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 100:10393–10398
Sun XF (2006) Clinicopathological and biological features of DNA tetraploid colorectal cancers. Cancer J 12:501–506
Susini T, Amunni G, Molino C, Carriero C, Rapi S, Branconi F, Marchionni M, Taddei G, Scarselli G (2007) Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called ‘low-risk’ patients with well and moderately differentiated tumors. Cancer 109:882–890
Swanton C, Nicke B, Schuett M, Eklund AC, Ng C, Li Q, Hardcastle T, Lee A, Roy R, East P, Kschischo M, Endesfelder D, Wylie P, Kim SN, Chen JG, Howell M, Ried T, Habermann JK, Auer G, Brenton JD, Szallasi Z, Downward J (2009) Chromosomal instability determines taxane response. Proc Natl Acad Sci USA 106:8671–8676
van de Vijver MJ, He YD, van’t Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999–2009
van’t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–536
Walther A, Houlston R, Tomlinson I (2008) Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 57:941–950
Weichert W, Roske A, Niesporek S, Noske A, Buckendahl AC, Dietel M, Gekeler V, Boehm M, Beckers T, Denkert C (2008) Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo. Clin Cancer Res 14:1669–1677 (an official journal of the American Association for Cancer Research)
Wik E, Trovik J, Iversen OE, Engelsen IB, Stefansson IM, Vestrheim LC, Haugland HK, Akslen LA, Salvesen HB (2009) Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting. Am J Obstet Gynecol 201(603):e601–e607
Witzig TE, Loprinzi CL, Gonchoroff NJ, Reiman HM, Cha SS, Wieand HS, Katzmann JA, Paulsen JK, Moertel CG (1991) DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma. Cancer 68:879–888
Yildirim-Assaf S, Coumbos A, Hopfenmuller W, Foss HD, Stein H, Kuhn W (2007) The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer. J Clin Pathol 60:649–655
Zarbo RJ, Nakhleh RE, Brown RD, Kubus JJ, Ma CK, Mackowiak P (1997) Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry. Cancer 79:2073–2086
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Gemoll, T., Auer, G., Ried, T., Habermann, J.K. (2015). Genetic Instability and Disease Prognostication. In: Ghadimi, B., Ried, T. (eds) Chromosomal Instability in Cancer Cells. Recent Results in Cancer Research, vol 200. Springer, Cham. https://doi.org/10.1007/978-3-319-20291-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-20291-4_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20290-7
Online ISBN: 978-3-319-20291-4
eBook Packages: MedicineMedicine (R0)